Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: J Ren Nutr. 2010 Jul 1;21(2):149–159. doi: 10.1053/j.jrn.2010.03.004

Table 1.

Baseline patient characteristics

Total
(n=32)
NS+EX
(n=15)
NS
(n=17)
P
Gender 0.53
  Male 21 (66) 9 (60) 12 (71)
  Female 11 (34) 6 (40) 5 (29)
Race 0.74
  African American 23 (72) 10 (66) 13 (76)
  Asian 1 (3) 1 (7) 0 (0)
  Caucasian 6 (19) 3 (20) 3 (18)
  Hispanic 2 (6) 1 (7) 1 (6)
Age (y) 43.2±13.1 46.5±12.1 40.2±13.5 0.17
BMI (kg/m2) 28.4±6.3 27.5±6.3 29.1±6.4 0.45
Etiology of ESRD 0.78
  Diabetes 6 (19) 3 (20) 3 (18)
  HTN 19 (59) 8 (53) 11 (65)
  Other 7 (22) 4 (27) 3 (18)
Other variables
  Hemoglobin (g/dL) 12.1±1.5 12.0±1.4 12.2±1.7 0.66
  Albumin (mg/dL) 41.2±2.9 40.7±2.8 41.8±3.0 0.40
  Creatinine (mg/dL) 10.1±2.5 9.3±2.5 10.9±2.3 0.09
  CRP (mg/L) 4.0(1.9~13.1) 4.3(1.9~13.3) 3.9(1.0~12.0) 0.52

Note: Values are mean ± SE,median (lower~upper quartile) or absolute numbers with percentages.

Abbreviation: NS+EX, nutrition supplementation plus exercise; NS, nutrition supplementation; BMI, body mass index; ESRD, end-stage renal disease; HTN, hypertension; CRP, C-reactive protein

HHS Vulnerability Disclosure